Advances in the Study of Invasive Non-mucinous Adenocarcinoma
with Different Pathological Subtypes / 中国肺癌杂志
Chinese Journal of Lung Cancer
;
(12): 22-30, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-971175
ABSTRACT
Lung cancer is the leading cause of cancer death in the world today, and adenocarcinoma is the most common histopathological type of lung cancer. In May 2021, World Health Organization (WHO) released the 5th edition of the WHO classification of thoracic tumors, which classifies invasive non-mucinous adenocarcinoma (INMA) into lepidic adenocarcinoma, acinar adenocarcinoma, papillary adenocarcinoma, solid adenocarcinoma, and micropapillary adenocarcinoma based on its histological characteristics. These five pathological subtypes differ in clinical features, treatment and prognosis. A complete understanding of the characteristics of these subtypes is essential for the clinical diagnosis, treatment options, and prognosis predictions of patients with lung adenocarcinoma, including recurrence and progression. This article will review the grading system, morphology, imaging prediction, lymph node metastasis, surgery, chemotherapy, targeted therapy and immunotherapy of different pathological subtypes of INMA.
.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Adenocarcinoma
/
Retrospective Studies
/
Adenocarcinoma of Lung
/
Lung Neoplasms
/
Lymphatic Metastasis
/
Neoplasm Staging
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Lung Cancer
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS